Examining changes in pain interference via pandemic-induced isolation among patients receiving medication for opioid use disorder: a secondary data analysis.  Frohe T, Janssen T, Garner BR, Becker SJ.  BMC Public Health. 2024 Sep 27;24...

Pharmacists' prescribing of opioids in Nova Scotia under Health Canada's Controlled Drugs and Substances Act temporary exemption during the COVID-19 pandemic.  Watema-Lord R, Sketris I, Neville H, Asbridge M, Sanyal C.  Can Pharm J (Ot...

Impact of COVID-19 on MOUD retention in a sample of rural primary care patients: A secondary analysis of electronic health records.  Calhoun S, Guo H, Fei Z, Lin C, Clingan SE, Zhu Y, Mooney LJ, Hser YI.  Drug Alcohol Depend Rep. 2024 ...

Association of chronic opioid therapy and opioid use disorder with COVID-19-related hospitalization and mortality: Evidence from three health systems in the United States.  Nguyen AP, Binswanger IA, Narwaney KJ, Ford MA, McClure DL, Rinehart...

The Odyssey of HOMER: Comparative Effectiveness Research on Medication for Opioid Use Disorder During the COVID-19 Pandemic.  Zittleman L, Westfall JM, Sofie B, Lutgen C, Fernald D, Hall TL, Hochheimer CJ, Murphy M, Felzien M, Dickinson LM, ...

Leveraging Policy Changes Made in Response to COVID-19 to Advance Telehealth and Novel Treatment Approaches for People Who Use Opioids: Qualitative Perspectives From Two Rural North Carolina Counties.  Chen H, Knettel BA, Macon Harrison L, D...